Insulet‘s patent involves a diabetes management system with a pump and control device featuring a user-friendly interface displaying blood glucose and insulin data. The system includes insulin pumps, glucose monitors, and mobile devices. A claim details a mobile computing device controlling an infusion pump system with a graphical user interface for data visualization. GlobalData’s report on Insulet gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights Insulet Corp - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Insulet, Wearable drug delivery devices was a key innovation area identified from patents. Insulet's grant share as of February 2024 was 80%. Grant share is based on the ratio of number of grants to total number of patents.

Mobile computing device for controlling medical infusion pump system

Source: United States Patent and Trademark Office (USPTO). Credit: Insulet Corp

A recently granted patent (Publication Number: US11929158B2) describes a mobile computing device designed to control a medical infusion pump system. The device includes a display screen, input controls, processors, and memory to store instructions enabling actions such as communicating with the pump system, receiving blood glucose level information, and providing a user-friendly interface. The interface features a blood glucose level chart and an insulin delivery chart, each with distinct vertical and time axes, ensuring no spatial overlap. The device also includes features like displaying current time, future projections, and differentiating between glucose values from different measurement devices.

Furthermore, the patent details a computer-implemented method and a non-transitory computer-readable medium with similar functionalities. These include communicating with the pump system, receiving blood glucose information, and presenting a graphical interface with separate charts for blood glucose levels and insulin delivery. The interface allows for easy visualization of data, including basal delivery rates and insulin bolus indicators, without overlapping information. Additional features like displaying current time, future projections, and differentiating between glucose values from various measurement devices enhance the usability and effectiveness of the device in managing medical infusion pump systems. Overall, the patent highlights innovative technology aimed at improving the control and monitoring of medical infusion pump systems through a user-friendly mobile computing device.

To know more about GlobalData’s detailed insights on Insulet, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.